Skip to main
LPTX

Leap Therapeutics (LPTX) Market Capitalization Overview

Market Cap: $65.72M as of Jan 8, 2026

$65.72M
$2.84M (4.50%)past month
As of Jan 8, 2026, Leap Therapeutics (LPTX) has a market capitalization of $65.72M. Over the past 30 days, its market cap has decreased by -8.13%, while in the last 12 months, it has increased by 0%.

Market capitalization represents the total value of Leap Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Leap Therapeutics (LPTX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Leap Therapeutics (LPTX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Leap Therapeutics (LPTX) Market Cap History

DateMarket CapChange
Dec 1, 2025$69.69M+193.56%
Nov 3, 2025$23.74M+8.92%
Oct 1, 2025$21.80M+78.57%
Sep 2, 2025$12.21M-3.76%
Aug 1, 2025$12.69M+3.27%
Jul 1, 2025$12.28M-17.35%
Jun 2, 2025$14.86M-13.66%
May 1, 2025$17.21M+43.16%
Apr 1, 2025$12.02M-25.89%
Mar 3, 2025$16.22M-19.14%
Feb 3, 2025$20.06M-83.75%
Jan 2, 2025$123.39M+11.03%

Leap Therapeutics (LPTX) End of Year Market Cap History

DateMarket CapChange
2026$65.72M0.00%
2025$65.72M-40.35%
2024$110.17M+3.96%
2023$105.97M+137.81%
2022$44.56M-84.43%
2021$286.16M

FAQs About Leap Therapeutics (LPTX) Market Cap

As of Jan 8, 2026, the market capitalization of Leap Therapeutics (LPTX) is $65.72M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Leap Therapeutics’s market capitalization has increased by 4.50%, changing from $62.89M to $65.72M as of Jan 8, 2026.

In the last 3 months, Leap Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Leap Therapeutics’s market capitalization decreased from $110.17M in January to $65.72M in December, reflecting a -40.35% change.

In the past five years, Leap Therapeutics (LPTX) has had a compound annual growth rate (CAGR) of -25.49% in market capitalization. This means its market cap has shrunk at an average rate of -25.49% per year.

Leap Therapeutics (LPTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.